Selective degeneration of striatal neurons is a pathologic hallmark of Huntington disease (HD). The exact mechanism(s) behind this specific neurodegeneration is still unknown.
INTRODUCTION
An important hallmark of HD is the selective neuronal degeneration in the caudate and putamen (together known as the striatum), which occurs despite the ubiquitous expression of mutant HTT throughout the brain and body of HD patients. This selective degeneration can be characterized by early striatal atrophy and neuronal dysfunction (1, 2) as well as 90% loss 4 the striatum compared to other brain regions) in a mouse model of HD as well as in human postmortem brain (5) . Interestingly, the product of these genes have been associated with biological processes previously implicated in HD (6) . Therefore, although results from brain global transcriptional analyses (7-10) have proven to be insightful, we propose that the study of striatal-enriched genes will more specifically contribute to our understanding of the unique striatal physiology and its selective susceptibility to degeneration in HD.
In this study, we analyzed the Serial Analysis of Gene Expression (SAGE) database from the Mouse Atlas of Gene Expression project (www.mouseatlas.org) (11) to compare the relative abundance of transcripts in normal striatum to that in eighteen other brain regions and thus to select for striatal-enriched genes. This Mouse Atlas project includes spatially and temporally restricted gene-expression profiles throughout murine development in a total of 200 cells and tissues (11) . SAGE is a relatively unbiased method for large-scale gene expression profiling as, unlike microarray methods, it does not require prior knowledge of the genes expressed. Thus, it has the potential to identify novel genes (12) .
We generated a list of novel striatal-enriched genes which included annotated transcripts not previously described as striatal-enriched as well as unannotated transcripts expressed specifically in the striatum. We analyzed the expression of the candidate genes in the YAC128 mouse model of HD. YAC128 mice express mutant HTT under its endogenous regulatory elements from a yeast artificial chromosome (YAC) transgene. YAC128 mice exhibit progressive motor dysfunction, cognitive impairment, impaired lifespan and progressive selective degeneration of specific neurons in the striatum thereby recapitulating many aspects of the human disease (13, 14) . By 12 months, there are clear reductions in striatal volume, striatal neuronal counts and striatal neuronal cross-sectional area in these mice (13) . Our recent studies have also identified HD-related transcriptional changes in this 5 mouse model at 12 months and 24 months using Affymetrix microarrays (9) (Becanovic et al., submitted). In the present study, we employed quantitative real-time PCR as a more sensitive method to detect changes in expression. We detected significant changes in the relative abundance of 11% of our candidate striatal-enriched transcripts in this mouse model at 12 months of age. Subsequent analysis of orthologous transcripts expression in human post-mortem caudate led to the identification of the adaptor-related protein complex 1, sigma 1 subunit (Ap1s1) and Cd4 Antigen (Cd4) as genes whose expression is significantly downregulated in both YAC128 mouse striatum and caudate from HD patients.
We propose that the study of genes with enriched striatal expression is a valid approach to identify candidate genes involved in HD pathogenesis.
RESULTS

Identification of striatal-enriched SAGE tags
To identify novel striatal-enriched transcripts, we compared the p84 SAGE library from striatum with libraries from eighteen other brain regions in this database. A set of stringent selection criteria (Fig 1. and MATERIALS AND METHODS) was developed to establish a list of novel striatal-enriched genes. The algorithm used to derive our candidate gene list is depicted in Fig.1 . To assess the validity of our SAGE analysis, we compiled a list of previously reported striatal-enriched genes from two publications, Desplat et al. and Chaldee et al. (5, 15) . These two studies encompass the most comprehensive list of known striatalenriched transcripts identified to date.
Striatal enrichment/specificity of a given transcript was determined based on its relative expression in striatum when compared to 18 other brain tissues. First, a comparison was made for adult (at 84 days postnatal (dpn)) brain libraries. There were 32,216 (potential 6 transcripts) unique tag sequences in the 84 dpn striatum library, of which 6,672 tagsequences were more abundant in the striatum than any other brain library by at least one absolute tag count (raw count in un-normalized library). This eliminated all tag-sequences that that were more abundant in any other brain region than in striatum. Of these tags, 6,044 tags were observed only once and were exclusive to the striatum (ie. one tag count in the striatum and zero elsewhere). These 'singletons' may result from sequencing and PCR errors or may well represent bona fide low-abundance transcripts in the tissue (11) . However, an un-biased and careful analysis of such a large number of tag-sequences and their corresponding transcripts was beyond the targeted scope of our analysis, and thus they were excluded from further consideration.
A p-value score (see MATERIALS AND METHODS) representing striatal enrichment for each tag relative to other brain regions was calculated and 268 of 628 non-singleton tags were significantly enriched. The abundance of the 268 tag-sequences was also compared among all eighteen brain libraries over five developmental time-points (pre-striatum, Theiler stage 25, and at dpns 7, 35 and 84) using the mean tag count. This tested whether or not a tag-sequence was preferentially expressed in striatum throughout development. This criterion eliminated 81 tags from further consideration but preserved all previously documented striatal-enriched genes among the 187 remaining tags.
Independent validation of striatal enrichment
SAGE measures absolute gene expression based on the sequencing of mRNA-derived fragments. However, SAGE libraries used in this project were constructed from a single individual mouse for each developmental time-point and this must be considered when performing comparisons. SAGE Libraries constructed from different individual mice, or mice kept in different laboratories show correlations of only 0.66-0.78, or 0.5-0.58 for counts 7 <100, even when the same inbred strain and tissues are used (12) . Thus, to further validate striatal enrichment of the selected tags, two subsequent analyses were performed. First, tagsequences representing known transcripts but lacking striatal-enriched expression patterns in the Allen Institute for Brain Science (AIBS) in situ hybridization images (n=82) were eliminated from the list (Fig. 1) .
At this stage, we gave consideration of the mapping of the tag sequences to identified genomic loci. Twenty three tags did not map to known genes. Fifteen of these tag-sequences either mapped to the mitochondrial genome or could not be definitely mapped to a single region in the mouse genome (ambiguous hits) using Refseq, Mammalian Gene Collection, and Ensembl. Of the ninety remaining unambiguous tag-sequences, fifty mapped to thirtyfour previously reported striatal-enriched genes ( Fig. 1) un-annotated region of the genome) ( Fig. 2A) and Tmem158 (Fig. 2B) are examples of significant striatal-enriched expression, Ap1s1 (Fig. 2C ) expression demonstrates a trend towards striatal enrichment, and Tmod1 (Fig. 2D) Based on the above validation, we identified thirty-four novel striatal-enriched transcripts (Table 2) .
Computational characterization and mapping of the novel striatal-enriched SAGE tags
Tag-to-gene mapping of the thirty-four novel striatal-enriched SAGE tags revealed that these tags represented twenty-three known genes, two uncharacterized transcripts, and two potential novel splice variants of known genes ( Table 2) . Among the known genes, cylindromatosis (turban tumor syndrome) gene (Cyld1), adaptor protein complex AP-1 sigma 1 (Ap1s1), phosphatase and actin regulator 1 (Phactr1) and protein phosphatase 1, regulatory (inhibitor) subunit 9A (Ppp1r9a) were represented by two or more enriched SAGE tags implying that two or more striatal-enriched splice variants exist for each of these genes.
There are two annotated splice-variants Cyld1, and three for Phactr1. This is consistent with the number of striatal-enriched SAGE tags selected for these genes. For Ppp1r9a, there are three documented transcripts one of which was not striatally-enriched. For Ap1s1, we selected two striatal-enriched tags, one of which corresponds to a splice-variant for this gene that has not previously been reported. Supplementary table 5 provides more descriptive 9 information regarding transcript titles and molecular functions of the 34 novel striatalenriched candidate transcripts obtained by our analysis.
Gene ontology (GO) provides standardized vocabulary to describe genes and their corresponding products. Using Expression Analysis Systematic Explorer (EASE) (http://david.abcc.ncifcrf.gov/), which provides statistical methods for discovering enriched biological themes within gene lists , we identified a wide range of classification throughout the list of candidate genes but no specific GO classes were over-represented in our novel striatal genes (data not shown).
The uncharacterized sequences to which our enriched tags mapped were identified as Riken transcripts C030013G03Rik and C030007I01Rik, an EST (BB360574), and also a genomic sequence that may contain a novel transcriptional unit ( Table 2 , tag #29). Tagsequence # 29 corresponds to a novel transcript on the negative strand of Chromosome 19 and may represent expansion of gene Gm705. There are no previously reported expression data for this region. These results further indicate our approach was successful in the identification of novel markers of striatal expression using SAGE. SAGE is outstanding for detecting putative new splice variants. This may include novel internal exons as well as novel alternative 3' untranslated regions (UTRs) (12) . As SAGE tags derive from the 3' most anchoring enzyme site in a transcript, many SAGE tags are expected to be derived from the 3' UTR which is not consistently included in gene predictions. Two of the novel striatal-enriched tag-sequences mapped to regions downstream of transmembrane protein 16C (Tmem16C) and phosphodiesterase 7b (Pde7b). AceView prediction (16) of alternate splicing exists ( Table 2 ). Both of these predictions have demonstrated homology to the human mRNA of the corresponding genes. Similarly, in the list of the previously reported striatal-enriched transcripts, mapping of SAGE tags to AceView predictions led to identification of potential novel splice-variants for previously-10 reported striatal-enriched genes such as adenylate cyclase 5 (Adcy5), diacylglycerol kinase, Dgkb, forkhead box P1 (FoxP1), Striatin (Strn), and cyclic AMP-regulated phosphoprotein, 21 (Arpp21) ( Table 1) .
Analysis of the candidate transcripts in the YAC128 mouse model of HD
We predicted that transcripts enriched in the striatum are relavant to the selective degeneration of this brain region in HD. Thus, expression levels of all thirty-four novel striatal-enriched transcripts were tested in 12-month-old YAC128 and wild-type mice using qRT-PCR. Through this analysis, we found that three genes exhibited a significant change in We further examined the expression of these three genes in YAC128 mice at 3 months of age. Only Indo mRNA was significantly up-regulated at this time-point (p = 0.039, N= 7 WT, type striatum but demonstrate a significant expression difference between YAC18 and YAC128 striatum. These results suggest that changes in Ap1s1, Cd4, and Indo are not due huntingtin dosage difference, but are likely to be a result of the expression of mutant huntingtin. The data are shown in supplemental figure 1.
Overall, having examined all thirty-four candidate striatal-enriched transcripts at 12 months, we identified three genes (containing four striatal-enriched transcripts) whose levels of mRNA expression were significantly changed in the striatum of YAC128 mouse model of HD. This indicated that ~ 11% of the novel striatal-enriched transcripts selected through our SAGE analysis showed significantly altered expression in this HD model.
Analysis of mouse striatal gene expression changes in the human HD caudate
To assess the relevance of the gene expression changes we observed in the YAC128 mouse model of HD, we assayed the expression of the differentially-regulated genes in caudate from HD patients and age-matched controls. Initially, PPP1R1B (DARPP32 mRNA) expression level was measured. This analysis was based on PPP1R1B previously-reported altered expression levels in human HD caudate and in different mouse models of HD such as YAC128, fragment protein models, and knock-in models (5, 9, 10, 19, 20) . These results were reproduced in our qRT-PCR analyses of human post-mortem caudate samples where PPP1R1B mRNA levels were significantly reduced in HD compared with controls ( Fig. 4A ).
qRT-PCR was also performed for human orthologs of Cd4, Ap1s1, and Indo. Human CD4 mRNA expression level was significantly increased in human HD caudate indicating an expression change opposite to what was observed in YAC128 striatum (Fig. 4B) . Finally, consistent with the mouse data in YAC128, human AP1S1 mRNA was shown for the first time, to be significantly reduced in human post-mortem HD caudate (Fig. 4C ). Despite being significantly enriched in mouse striatum, human INDO transcript has unexpectedly low 12 abundance in human HD and control post-mortem tissues and to date, and has not been detected in our qRT-PCR experiment. As an example of an unknown striatal-enriched transcript with un-altered levels of expression in the YAC128 mice, human ortholog of Gm705 transcript also exhibited no transcriptional change in human HD samples.
DISCUSSION
This project identified a novel set of striatal-enriched transcripts from an existing SAGE database, compared the expression levels of these transcripts in the striatum of wild-type and YAC128 transgenic mice, and further evaluated those transcripts with altered expression in caudate samples from post-mortem HD and control brain.
The transcripts selected through our SAGE analysis are novel in two ways: 1) They have not been previously described as striatal-enriched by other studies. 2) They are novel transcripts that were never discovered before. In either case, previous studies have failed to detect them using other techniques. SAGE allows the detection of tissue-specific lowabundance transcripts which normally remain undetectable using other techniques. SAGE also allows for the discovery of novel transcripts, without a priori selection bias, while other techniques such as microarrays lack this advantage. Finally, the digital nature of SAGE tags makes them easy to handle in computational analyses. In our study 19 brain regions are easily compared. The high efficiency of this screen suggests that the MouseAtlas SAGE library database is a powerful resource to identify tissue-specific transcripts.
Confirmation of previously reported striatal-enriched genes
Although the goal of this project was to identify novel striatal-enriched genes from an existing SAGE database using a defined selection algorithm, we also assessed the selection of previously-reported striatal-enriched genes at each selection step to ensure the validity of 13 our selection process. Accordingly, while identifying novel striatal-enriched transcripts, we were also able to detect a large proportion of the striatal-enriched genes previously reported by de Chaldee et al. and Desplats et al. (5, 15) . We considered four main reasons why not all of the previously reported genes met our selection criteria: 1). Our initial selection criteria required striatal-enriched SAGE tags to be more abundant in the striatum than other brain regions at dpn 84. As an example, the previously reported striatal-enriched transcript retinoic acid receptor beta (Rarb) is highly expressed in striatum at dpn 7 and dpn 37, but not at dpn 84. Therefore, this transcript and other similar transcripts that are transiently enriched during striatal development are absent from our striatal-enriched candidate list.
2). We compared expression data for 18 different brain regions in this study and selected for SAGE tags that had higher counts in the striatum than all eighteen other brain regions.
Therefore, SAGE tags that manifest higher or equal abundance in at least one other brain region were eliminated. The hippocalcin (Hpca) SAGE tag which was highly abundant in the striatum, showed a higher expression in CA1 and the neuronal guanine nucleotide exchange factor (nGEF) SAGE tag which was more abundant in visual cortex than in the striatum.
These genes and other previously reported striatal-enriched genes were found to be highly expressed in the striatum, but were expressed at higher levels in at least one other brain region (e.g. synaptoporin) and based on our selection criteria, these genes are not considered striatal-enriched in this analysis.
3). Low abundance transcripts may not be detected by this specific SAGE analysis or may be at the singleton level, which were excluded based on our selection criteria. The SAGE tag for Htr6 gene (5-hydroxytryptamine (serotonin) receptor 6) was excluded as a singleton. 4). Transcripts lacking the appropriate anchoring enzyme site (e.g. NlaIII) will never appear in SAGE libraries as no tag for these genes will be extracted (12) . Similarly, since 14 SAGE relies on a polyadenylated tail for tag extraction, transcripts that are not polyadenylated will be absent. Dopamine receptor 3 (Drd3) fails to have a valid SAGE tag since its annotated transcript lacks a poly-A tail. Therefore, despite being abundant in the striatum, many previously-reported striatal-enriched transcripts were excluded from our candidate gene list due to our specific selection criteria. Table 3 summarizes why some documented striatal-enriched genes were excluded by our criteria.
In selecting our list of candidate striatal-enriched genes, we employed statistical filtration and in situ hybridization images from the AIBS database. The use of AIBS database was beneficial since it provided a more clear understanding of patterns of expression of annotated transcripts. The estimated correlation rate between SAGE and AIBS for known candidate transcripts was approximately 50% in our analysis. In a recent cDNA microarray study by Ghate et al. (2007) , the majority of their novel striatal genes did not demonstrate clear striatal enrichment in their in situ images in AIBS leading to questions regarding the sensitivity of this resource (21) . Overall, the semi-quantitative and spatially restricted expression data provided by in situ images was complementary to our study. However, AIBS data in isolation is not a pragmatic source for evaluating un-annotated transcripts.
Quantitative RT-PCR was used as another means to further validate selection of our candidate gene list. Unlike the Mouse Atlas of Gene Expression and AIBS datasets, multiple animals were tested, resulting in a more robust analysis of transcript expression patterns within the brain. Moreover, relative expression of all transcripts, including unknown transcribed regions, was accessible for analysis using this technique. Using qRT-PCR analysis, 18 transcripts from our candidate list (45%) were significantly enriched in striatum, and 15 transcripts (37 %) showed a robust trend towards striatal enrichment. In a previous study using qRT-PCR analysis of mouse genes identified by SAGE, a correlation of 0.64 between the two methods was found, but this study only examined tags with counts greater than 45 (22) . The lower correlation in our analysis could be due to the lower abundance of tags assessed (only required to be >1 count) with the majority of our candidate transcripts expressed at less than 45 counts. Similar reasoning could be used to explain the 7 out of 40 (17%) transcripts that were less abundant in striatum than at least one other tissue using qRT-PCR. These data indicate that more abundant transcripts are more likely to be validated using techniques such as qRT-PCR.
Identification and characterization of novel striatal-enriched transcripts
Computational analysis of our novel candidate list of striatal-enriched SAGE tags revealed twenty-six known genes, four uncharacterized transcripts, and two putative novel splice variants of previously annotated genes ( Table 2) . Trans-membrane protein 158 (Tmem158), also known as Ras-induced senescence 1, had the highest p-value score and was validated by qRT-PCR (Fig. 2B) . Tmem158 was previously implicated in cancer (23) and can elicit new mechanisms in striatal physiology. The transcript in Table 2 with the highest mean ratio was indoleamine-pyrrole 2,3 dioxygenase (Indo), a gene involved in tryptophan metabolism (Sup. fig. 2 ). Indo is striatally-enriched throughout striatal development and this expression pattern was validated using qRT-PCR (data for other time points not shown).
Similarly, 3 variants of the phosphatase and actin regulator 1 (Phactr1) were selected as striatal-enriched transcripts. Phactr1 has been found to inhibit protein phosphatase 1 (PP1) activity and also known to bind to actin. Phactr1 is thought to dictate PP1 subcellular localization and in some cases serve to potentiate PP1 toward select substrate at those sites (24) . A recent study by Shao et al. demonstrated that phosphorylation of an actin-binding factor protein profilin, regulates polyglutamine aggregation (25) . Although we found no difference in the level of Phactr1 in WT vs. YAC128 animals, future investigation is required to determine the role of Phactr1 in phosphorylation of actin cytoskeleton components and how striatal-enrichment of this gene may lead to striatal vulnerability to neurodegeneration. Cyld is another interesting striatal-enriched candidate gene whose two different variants were selected through our analysis. SAGE analysis, Allen Brain Atlas, and qRT-PCR results all indicate highly enriched patterns of expression in the striatum. The deubiquitinating enzyme CYLD is a tumor suppressor protein known to repress the NF-kB activation pathway (26) . The activation of this pathway is known to have anti-apoptotic role and may play a role in response to injury in the CNS. We have not observed any significant difference in Cyld expression in YAC128 vs. wild-type animals. However, Cyld remains an important candidate for future studies of striatal-enriched proteins. Computational analysis also led to the selection of four unknown striatal-enriched transcripts one of which (tag # 29 in Table 2 ) maps to an un-annotated region of the Chromosome 18 genomic sequence. The striatal enrichment of this transcribed region has also been shown in our study using qRT PCR ( Fig. 2A) . This novel striatal-enriched tag-sequence may represent an alternative splice variant of the transcriptional unit which also encompasses the SAGE tag located in a highlyconserved striatal-enriched gene Gm705 (described as a striatal-enriched EST AI836640 in Desplats et al.) also selected in our analysis (Table 1, tag # 11).
Altered expression levels of candidate striatal-enriched genes in the YAC128 mouse model of HD and human post-mortem HD brain
Next, we investigated the expression levels of the candidate novel striatal-enriched transcripts selected by our analysis in both the YAC128 mouse model of HD and in human post-mortem HD caudate. Selective striatal degeneration in the YAC128 mice manifests as striatal atrophy beginning at 9 months progressing to significant neuronal loss at 12 months of age (13) . 12-month-old YAC128 mice also have profound motor deficits and show clear patterns of cognitive dysfunction appearing as decreased pre-pulse inhibition and habituation to acoustic startle (14) . Based on the presence of striatal neuropathology, motor dysfunction, and cognitive phenotypes at 12 month in YAC128 mice, striatal transcription was tested at this time-point. One of the three novel striatal-enriched genes with altered mRNA expression in YAC128 mice was Cd4. The Cd4 antigen is a membrane glycoprotein of T lymphocytes that interacts with major histocompatibility class II (MHC II) antigens and is also a receptor for the human immunodeficiency virus (HIV). The gene is known to be expressed highly in thymus and spleen but also lower levels are found in microglia in the brain (28) . Transgenic mice expressing the human CD4 gene showed no evidence of neuronal damage until their brain was activated by peripheral immune challenges which led to neurodegeneration in these mice (10) . In post-mortem brain tissues from AIDS patients with opportunistic infections, but without typical HIV encephalitis, human CD4 expression correlated with neurodegeneration (10) . Our finding that Cd4 is a striatal-enriched gene may explain the susceptibility of the striatum to neuroinflammation observed in HD (29) and may provide mechanistic insight into selective striatal degeneration in HD. We demonstrate that CD4 transcript expression is significantly up-regulated in human HD caudate samples compared to controls, implying that there is altered immune activation in the striatum of HD patients. However, the observed discrepancy in Cd4 expression change between human postmortem caudate and YAC128 striatum raises interesting questions regarding the regulation of this transcript in postmortem human brain versus mouse brain and its potential link to disease progression in mouse and human. Further investigation is required to first understand which brain cell types in the striatum of YAC128 and patients express Cd4 (ie. glial cells vs. MSNs) and to subsequently explain the role of Cd4 expression in the context of neurodegeneration in HD.
Indo, another gene with altered mRNA expression levels in the YAC128 mouse model, is a tryptophan-catabolizing enzyme which initiates the first and rate limiting step of the kynurenine pathway. In the brain, Indo can be induced in microglia by interferon-γ-producing T helper (Th) 1 cells. Indo is thought to initiate a negative feedback loop which decreases neuroinflammation in an animal model of multiple sclerosis (MS) (30) (31) (32) . On the other hand, induction of Indo activates the, kynurenine pathway leading to production of neurotoxic metabolites such as 3 hydroxy-Kyurenine and quinolinic acid known to be involved in HD pathogenesis (33) . Accordingly, Kiwidzinski and Bechmann (2007) have proposed that neuroinflammation and neurodegeneration are linked by IFN-γ-mediated Indo induction (34) . In a recent expression study of amyloid ß peptide-stimulated human postmortem brain microglia, the INDO protein was found to be up-regulated identifying a potential new inflammatory pathway in Alzheimer's disease (35) The observed increase in Indo mRNA expression in the YAC128 mice could suggest for the first time, a similar involvement of Indo leading to neuroinflammation described in HD (29) . Expression levels of INDO mRNA in the human post-mortem brain were also assessed by qRT-PCR, however this analysis was not conclusive (poor amplification) due to very low levels of INDO mRNA in both HD and control caudate RNA samples. It is known that RNA degradation in autopsy tissue is more severe in specific subsets of transcripts or restricted to specific gene families 
Summary
Through the use of publicly available datasets and experimental techniques, we have identified candidate genes with altered expression in the striatum of a murine HD model and in human HD caudate. The products of these genes may be involved in pathways that are relevant to HD pathogenesis, be useful as biomarkers to follow disease progression, and may be potential new therapeutic targets for the treatment of HD.
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MATERIALS AND METHODS
SAGE data analysis
SAGE libraries (Supplementary table 1) were generated by the Mouse Atlas of Gene Expression Project (www.mouseatlas.org). The DiscoverySpace software application (http://www.bcgsc.ca/bioinfo/software/discoveryspace/) was used to compare the striatum library to 18 other brain region libraries at dpn 84. These libraries were compared to the striatum library one at a time after tag counts in each library were normalized to that of the striatum library (total of 18 pairwise comparisons). A "p-value score" for each striatal tagsequence was obtained by calculating the sum of (1-p-values) for that tag in all pairwise comparisons (p-values obtained using Audic Claverie statistics): P-value score for tag x = Σ Candidate striatal-specific tags were selected based on the following selection criteria: 1) more abundant in striatum, by at least one tag count, compared to 18 other brain libraries at dpn 84, 2) p-value score ≥ 13.0 at dpn 84 where -16 ≤ p-value score ≤ +17, and 3) mean ratio ≥ 2.5 when all striatum libraries (n=5) were compared to 18 other libraries at all available time-points (total of 40 libraries). Tag to gene mapping was performed using the mouse Refseq, MGC, and Ensembl databases accessible through DiscoverySpace. Tag position was determined as a number whose figure represented the location of the NlaIII site relative to the polyA tail and whose sign represented the directionality of the tag relative to the gene to which it was mapped.
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In situ hybridization database Allen Brain Atlas (AIBS) (http://www.brainatlas.org/AIBS/) in situ hybridization images provided a visual assessment of relative abundance of the transcript corresponding to each SAGE tag mapping to annotated gene. Clearly, only SAGE tags mapping to known genes could be filtered through this process. A demonstrated striatal-enriched/specific expression pattern in the AIBS in situ hybridization database was considered a necessary criterion in our analysis. SAGE tags corresponding to unknown regions were not filtered out at this stage. 
Quantitative real-time PCR
Mouse experiments
For SAGE validation experiments, RNA from 4 brain regions (striatum, cortex, cerebellum, hippocampus) as well as liver and gastrocnemius muscle was prepared from three 3-month-old mice using the RNeasy kit (Qiagen). Similarly, for transgenic and WT 23 comparison experiments, RNA was extracted from fresh-frozen dissected striata of eleven wild-type and eight YAC128 transgenic 12-month-old littermate mice. RNA was also extracted from six 12-month-old YAC18 animals for YAC18 vs. YAC128 comparison experiments.
Primers were designed using Primer3 (http://frodo.wi.mit.edu/cgibin/primer3/primer3www.cgiT) and amplicons spanned introns where possible. Amplicons were between 110 and 150 bp for efficient amplification. Primer efficiencies were determined using a dilution series of adult striatum cDNA. Only primers pairs with an efficiency greater than 0.98 were used in subsequent analyses. The primers were also designed to encompass the SAGE tag (See supplementary table 2 for the list of mouse primers). An ABI 7000 real-time PCR system (Applied Biosystems) and SYBR ® Green
Master mix (Qiagen) were used for validations of the SAGE data. An ABI 7500 real-time PCR system (standard protocol) and SYBR ® Green Master mix (Qiagen) were used to compare wild-type and YAC128 mRNA. cDNA was obtained by the reverse transcription (RT) of 1 µg of total RNA from freshly dissected brain regions using the Quantitect RT kit (Qiagen). All reactions were carried out in duplicate using 2 µl of cDNA in each reaction.
Duplicates with inconsistent amplification were removed from the analysis. Absolute quantity of the targets in each sample was calculated based on the standard curve method and normalized to endogenous control, β-actin (reverse primer sequence:
5'TGTGTTGGCATAGAGGTCTTTACG3'; forward primer sequence:
Human post-mortem experiments RNA was extracted from 11 brain samples listed in supplementary table 1 using the RNeasy kit (Qiagen). Primers were designed similar to mouse primers against human genome for human AP1S1, CD4, INDO, and DARPP32. Primer efficiencies were determined as in mouse experiments. An ABI 7500 real-time PCR system (Fast protocol) using ABI Fast 24 SYBR Green Master mix (Applied Biosystems) was used. All reactions were carried out in duplicates. For the analysis, relative quantity was calculated based on the standard curve method. Supplementary table 3 contains the human specific primers designed for qRT-PCR experiments. We analyzed multiple control genes (GAPDH, β-ACTIN, phosphoglycerate kinase 1 (PGK1) for normalization of the human qRT-PCR data. We applied the GeNorm software analysis for calculation of the most accurate normalization factor for our data measurements (39) . The normalization factor (NF) was based on geomethric averaging of multiple internal control genes and calculations were based on the average expression stability and pairwise variation analysis using the GeNorm-software
Statistical Analysis
In SAGE validation experiments, a one-way ANOVA was performed for determining differences in the relative quantity of targets of interest between different tissues. Statistical comparisons were performed in a pair-wise fashion between striatum and every other tissue.
In WT versus transgenic experiments, a two-tailed Student's t-test was performed for determining differences in the mean between the two groups and Levene's test to determine equality of variance. Differences were assumed statistically significant if they reached the 95 % confidence level. All values are represented as averages with standard error of the mean. Figure 1 . Selection algorithm identified novel striatal-enriched transcripts. We defined "striatal-enriched" transcripts as transcripts with dominant patterns of expression in striatum compared to 18 other brain regions. Accordingly, selection criteria were designed to maximize detection of previously-known striatal-enriched genes. Enrichment of a SAGE tag in the striatum relative to other regions was determined by using a p-value score ≥ 13 at postnatal day (dpn) 84 and mean ratio of ≥ 2.5 at all available time-points. These two filtering steps reduced the number of tags to 187 consisting of tag-sequences mapping to both known and unknown regions of the genome. Striatal enrichment seen in Allen Institute for Brain Science (AIBS) in situ database images and quantitative real-time PCR were also used for further filtration of the SAGE tags. These selection criteria led to the identification of 34 novel striatal-enriched tags which corresponded to 23 known genes, 4 uncharacterized genes, and 2 novel splice variants of known genes. qRT-PCR experiments for these transcripts revealed 3 groups of candidate transcripts: 1) transcripts whose expression was shown to be significantly higher in the striatum 2) transcripts that show a trend towards striatal enrichment, and 3) transcripts that showed lower expression levels in the striatum compared with at least one other tissue. A cross comparison between the expression levels in striatum, cortex, hippocampus, cerebellum, liver, and muscle using qRT-PCR revealed Gm705 expansion, a previously unknown striatal-enriched transcript (a), and Tmem158, a transcript not previously known to be striatal-enriched (b) were significantly higher in the striatum; Ap1s1, a transcript selected by SAGE showed a trend towards striatal enrichment (c); for transcript Trom1, striatal-enrichment was not validated using qRT-PCR (d). Overall, out of 40 transcripts, 45% showed a significantly higher level in striatum, 37 % showed a trend towards striatal enrichment, and 17% showed lower levels of expression in striatum than at least one other tissue. Error bars represent SEM. Significant differences were determined by a one-way ANOVA analysis using a threshold value of p<0.05. The qRT-PCR results for rest of the candidate transcripts are in supplementary figure 2. Relative quantification of the mRNA levels of 34 novel striatal-enriched transcripts in the striatum of 12-month-old YAC128 mice revealed the greatest mRNA changes for Ap1s1 (a) and Cd4 (b) and Indo (c). These transcripts were also tested at three months and only Indo mRNA expression exhibited a significant up-regulation at both 12 months and 3 months of age (c). As expected, well-known striatal transcripts, Ppp1r1b and Gnal showed significant changes at 12 months (d, e). Tmem158 is an example of a striatalenriched gene with no alteration in expression level in the YAC128 mice (f). Error bars represent SEM. Significant differences were determined by student's t-test (unpaired; twotailed) using a threshold value of p<0.05. Transcripts that were differentially expressed in the YAC128 mouse model of HD were tested in human postmortem caudate samples from HD patients and age-matched controls. PPP1R1B (a) and AP1S1 (c) showed significant down-regulation in HD subjects compared with controls, similar to expression changes observed in the YAC128 mouse model. CD4 (b) was significantly up-regulated in HD subjects compared with controls, opposite to the change observed in theYAC128 mouse model. Error bars represent SEM. Significant differences were determined by student's t-test (unpaired; twotailed) using a threshold value of p<0.05. * p-value score indicates relative enrichment of the SAGE tag in the striatum at 3 months †mean ratio indicates relative enrichment of the SAGE tag in the striatum through five developmental time-points 
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